Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cherie Booth QC opens world-leading genomics research facility at CCLRC Daresbury Laboratory

31.01.2005


Cherie Booth QC today opened a world-leading facility at CCLRC Daresbury Laboratory which is designed to understand how genes make proteins. The £3 million facility will use powerful X-rays from Daresbury Laboratory’s Synchrotron Radiation Source and advanced automation techniques to solve complex protein structures. This will underpin advances in research and healthcare.



The facility, a new beamline on Daresbury Laboratory’s Synchrotron Radiation Source (SRS), is a collaboration between the Laboratory and Liverpool John Moores, Liverpool and Manchester Universities, Astra Zeneca and Astex Technology.

Cherie Booth QC, Chancellor of Liverpool John Moores University, said, ‘I am delighted to open this world-leading research tool. Advanced facilities of this kind are vital if the UK is to take a lead in using the information contained in our genes to develop new medicines and improve the quality of life for millions around the world.’


The information contained in the genes of living organisms is a blueprint to allow a cell to make a protein. Proteins are the workhorses of the cell and carry out the essential functions that keep us alive. Where genes are faulty through, for example, inherited disease then they can make proteins which either don’t work or don’t work correctly. In order to develop medicines to treat these diseases researchers need to know the three-dimensional structure of the proteins at atomic detail. It is this essential information which the new structural genomics facility at Daresbury Laboratory will provide.

Professor Samar Hasnain, co-ordinator for the North West Structural Genomics Centre, said, ‘In addition to work on genetic diseases, this world-leading facility will allow us to begin to translate gene sequences directly into protein structures – an essential step for understanding the biology of how pathogens affect humans. Many of these protein structures could become future targets for new drugs and medical treatments.’

Tony Buckley | alfa
Further information:
http://www.cclrc.ac.uk

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

Construction of practical quantum computers radically simplified

05.12.2016 | Information Technology

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>